Ebselen: A Promising Repurposing Drug to Treat Infections Caused by Multidrug-Resistant Microorganisms
Bacterial multiresistance to drugs is a rapidly growing global phenomenon. New resistance mechanisms have been described in different bacterial pathogens, threatening the effective treatment of even common infectious diseases. The problem worsens in infections associated with biofilms because, in ad...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hindawi Limited
2024-01-01
|
| Series: | Interdisciplinary Perspectives on Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/2024/9109041 |
| _version_ | 1797220308259700736 |
|---|---|
| author | Agostinho Alves de Lima e Silva André Rio-Tinto |
| author_facet | Agostinho Alves de Lima e Silva André Rio-Tinto |
| author_sort | Agostinho Alves de Lima e Silva |
| collection | DOAJ |
| description | Bacterial multiresistance to drugs is a rapidly growing global phenomenon. New resistance mechanisms have been described in different bacterial pathogens, threatening the effective treatment of even common infectious diseases. The problem worsens in infections associated with biofilms because, in addition to the pathogen’s multiresistance, the biofilm provides a barrier that prevents antimicrobial access. Several “non-antibiotic” drugs have antimicrobial activity, even though it is not their primary therapeutic purpose. However, due to the urgent need to develop effective antimicrobials to treat diseases caused by multidrug-resistant pathogens, there has been an increase in research into “non-antibiotic” drugs to offer an alternative therapy through the so-called drug repositioning or repurposing. The prospect of new uses for existing drugs has the advantage of reducing the time and effort required to develop new compounds. Moreover, many drugs are already well characterized regarding toxicity and pharmacokinetic/pharmacodynamic properties. Ebselen has shown promise for use as a repurposing drug for antimicrobial purposes. It is a synthetic organoselenium with anti-inflammatory, antioxidant, and cytoprotective activity. A very attractive factor for using ebselen is that, in addition to potent antimicrobial activity, its minimum inhibitory concentration is very low for microbial pathogens. |
| first_indexed | 2024-04-24T12:47:28Z |
| format | Article |
| id | doaj.art-08af6641403b4c678055a336f15c1c41 |
| institution | Directory Open Access Journal |
| issn | 1687-7098 |
| language | English |
| last_indexed | 2024-04-24T12:47:28Z |
| publishDate | 2024-01-01 |
| publisher | Hindawi Limited |
| record_format | Article |
| series | Interdisciplinary Perspectives on Infectious Diseases |
| spelling | doaj.art-08af6641403b4c678055a336f15c1c412024-04-07T00:00:01ZengHindawi LimitedInterdisciplinary Perspectives on Infectious Diseases1687-70982024-01-01202410.1155/2024/9109041Ebselen: A Promising Repurposing Drug to Treat Infections Caused by Multidrug-Resistant MicroorganismsAgostinho Alves de Lima e Silva0André Rio-Tinto1Laboratory of Biology and Physiology of MicroorganismsLaboratory of Pathogenic Cocci and MicrobiotaBacterial multiresistance to drugs is a rapidly growing global phenomenon. New resistance mechanisms have been described in different bacterial pathogens, threatening the effective treatment of even common infectious diseases. The problem worsens in infections associated with biofilms because, in addition to the pathogen’s multiresistance, the biofilm provides a barrier that prevents antimicrobial access. Several “non-antibiotic” drugs have antimicrobial activity, even though it is not their primary therapeutic purpose. However, due to the urgent need to develop effective antimicrobials to treat diseases caused by multidrug-resistant pathogens, there has been an increase in research into “non-antibiotic” drugs to offer an alternative therapy through the so-called drug repositioning or repurposing. The prospect of new uses for existing drugs has the advantage of reducing the time and effort required to develop new compounds. Moreover, many drugs are already well characterized regarding toxicity and pharmacokinetic/pharmacodynamic properties. Ebselen has shown promise for use as a repurposing drug for antimicrobial purposes. It is a synthetic organoselenium with anti-inflammatory, antioxidant, and cytoprotective activity. A very attractive factor for using ebselen is that, in addition to potent antimicrobial activity, its minimum inhibitory concentration is very low for microbial pathogens.http://dx.doi.org/10.1155/2024/9109041 |
| spellingShingle | Agostinho Alves de Lima e Silva André Rio-Tinto Ebselen: A Promising Repurposing Drug to Treat Infections Caused by Multidrug-Resistant Microorganisms Interdisciplinary Perspectives on Infectious Diseases |
| title | Ebselen: A Promising Repurposing Drug to Treat Infections Caused by Multidrug-Resistant Microorganisms |
| title_full | Ebselen: A Promising Repurposing Drug to Treat Infections Caused by Multidrug-Resistant Microorganisms |
| title_fullStr | Ebselen: A Promising Repurposing Drug to Treat Infections Caused by Multidrug-Resistant Microorganisms |
| title_full_unstemmed | Ebselen: A Promising Repurposing Drug to Treat Infections Caused by Multidrug-Resistant Microorganisms |
| title_short | Ebselen: A Promising Repurposing Drug to Treat Infections Caused by Multidrug-Resistant Microorganisms |
| title_sort | ebselen a promising repurposing drug to treat infections caused by multidrug resistant microorganisms |
| url | http://dx.doi.org/10.1155/2024/9109041 |
| work_keys_str_mv | AT agostinhoalvesdelimaesilva ebselenapromisingrepurposingdrugtotreatinfectionscausedbymultidrugresistantmicroorganisms AT andreriotinto ebselenapromisingrepurposingdrugtotreatinfectionscausedbymultidrugresistantmicroorganisms |